Pharmaceuticals and healthcare

Richard Grimshaw successful in appeal

Richard Grimshaw appeared for the Claimant/Respondent in an appeal concerning the refusal by a district judge to grant relief from sanctions to the Defendant/Appellant in a moderately high value and complex clinical negligence case. The Defendant applied for an extension of time to serve a witness statement from a clinician after the deadline for exchanging […]

Clinical negligence trial sees damages awarded of £1.5m in Cauda Equina syndrome case

Clinical negligence experts from No5 Barristers’ Chambers have seen the successful conclusion of a claim involving Cauda Equina Syndrome with damages agreed at around £1.5million. Jonathan Jones QC and David Tyack, with Moosa Duke solicitors, represented the claimant, 37, who had a long history of back pain. The defendant NHS Trust was represented by Michael […]

Fieldfisher

Fieldfisher loses third life sciences partner in four months

Fieldfisher has lost a London partner to US firm Arnold & Porter, in a move that marks yet another blow to Fieldfisher’s IP and life sciences practice following a string of departures. Partner Beatriz San Martin has joined the US firm having spent over a decade at Fieldfisher. She joined in 2004 and ascended to […]

DLA Piper roundtable: Dealing with the rise of digital therapeutics

The Lawyer, in association with DLA Piper, recently hosted a roundtable focusing on the growing number of obstacles and opportunities faced by law firms and businesses alike when working with digital therapeutics Co-moderators Roger Wagland – Research and digital product director, The LawyerTom Heylen – partner, DLA Piper Gareth Stokes – partner, DLA Piper Round […]

Novartis keeps firms waiting for results of global panel review

Swiss pharmaceutical powerhouse Novartis is nearing the end of its global legal panel review, which is understood to have been launched earlier this year. The panel is underway following the appointment of GC Shannon Thyme Klinger, who took on the role in June 2018, replacing Felix Ehrat. Her appointment came four months after Novartis also […]

Kirkland among US firms acting on $90bn pharma merger

Kirkland & Ellis, Sullivan & Cromwell and Arnold & Porter Kaye Scholer are the firms involved in the latest deal between US pharmaceutical giants, Bristol-Myers Squibb, Celgene and Amgen, valued at $13.4bn. The deal is related to the $90bn merger between the Bristol-Myers Squibb and Celgene, announced in January, and the sale of Celgene’s skin […]

Taylor Wessing rebuilds life sciences group with Fieldfisher hire

A month after the firm lost four life sciences and technology partners to Goodwin Procter, Taylor Wessing has started to reassemble its group with a new hire from Fieldfisher. Fieldfisher’s former life sciences and healthcare head Alison Dennis is to join Taylor Wessing after over a decade at Fieldfisher. As the head of the group, […]

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

View our subscription options

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here